The BMJ Group, one of the world's most trusted providers of medical information for doctors, researchers, healthcare workers and patients, has appointed Dr Justin Whatling as a non-executive director.

Dr Whatling is currently Director of Global Healthcare Strategy & Planning at BT and Visiting Professor in the Centre for Health Infomatics and Multiprofessional Education at University College London.

A qualified physician, Dr Whatling trained in medicine in London and also has a degree in molecular biology. Since practicing in the field of neurology, Dr Whatling has acquired significant experience of health informatics and health outcomes in the business sector.

Stella Dutton, CEO of BMJ Group, said:

“Dr Whatling brings to the BMJ Group a wealth of experience in both medicine and the application of technology to the delivery of medical information for doctors and patients. His expertise will be invaluable in helping us to shape the Group’s future strategy and ensure that we continue to be known and trusted around the world for the quality and influence of our content."

Dr Whatling said:

“The BMJ Group brand stands for medical credibility. I am therefore excited at the opportunity of becoming involved with the Group and helping to develop new products and services that will improve medical outcomes for patients."